human | Q5 |
P269 | IdRef ID | 077283465 |
P213 | ISNI | 0000000357106060 |
P496 | ORCID iD | 0000-0003-0928-0048 |
P1053 | ResearcherID | L-9483-2013 |
P214 | VIAF ID | 196013383 |
P184 | doctoral advisor | Sabine Colnot | Q30512422 |
P735 | given name | Thomas | Q16428906 |
Thomas | Q16428906 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | male | Q6581097 |
Q57756525 | A Hepatocellular Carcinoma 5-Gene Score Associated With Survival of Patients After Liver Resection |
Q86844817 | ALDH3A1 is overexpressed in a subset of hepatocellular carcinoma characterised by activation of the Wnt/ß-catenin pathway |
Q60904398 | Activer un signal bêta-caténine dans le foie est oncogénique |
Q45980006 | Brivanib in patients with advanced hepatocellular carcinoma who were intolerant to sorafenib or for whom sorafenib failed: results from the randomized phase III BRISK-PS study. |
Q104560036 | Circulating IL-13 Is Associated with De Novo Development of HCC in HCV-Infected Patients Responding to Direct-Acting Antivirals |
Q61800031 | Circulating and Hepatic BDCA1+, BDCA2+, and BDCA3+ Dendritic Cells Are Differentially Subverted in Patients With Chronic HBV Infection |
Q38342390 | Clinical trial watch: reports from the AASLD Liver Meeting®, Boston, November 2014. |
Q51740036 | Combination of AKT inhibitor ARQ 092 and sorafenib potentiates inhibition of tumor progression in cirrhotic rat model of hepatocellular carcinoma. |
Q40224423 | Comparison of two techniques of transarterial chemoembolization before liver transplantation for hepatocellular carcinoma: a case-control study. |
Q48137167 | Correction to: Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful? |
Q48354879 | Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful? |
Q38410139 | Differentiation of focal nodular hyperplasia from hepatocellular adenoma: Role of the quantitative analysis of gadobenate dimeglumine-enhanced hepatobiliary phase MRI. |
Q88202976 | Efficacy of AKT Inhibitor ARQ 092 Compared with Sorafenib in a Cirrhotic Rat Model with Hepatocellular Carcinoma |
Q35925442 | Functional imaging of hepatocellular carcinoma using diffusion-weighted MRI and (18)F-FDG PET/CT in patients on waiting-list for liver transplantation. |
Q42345365 | Hepatitis E Virus Infection after Platelet Transfusion in an Immunocompetent Trauma Patient. |
Q53824769 | Hepatocellular carcinoma is diagnosed at a later stage in alcoholic patients: Results of a prospective, nationwide study. |
Q43948766 | Imaging benign hepatocellular tumors: atypical forms and diagnostic traps. |
Q46971158 | Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time. |
Q81881751 | Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma |
Q43492530 | Impact of tumour differentiation to select patients before liver transplantation for hepatocellular carcinoma. |
Q24611474 | International network of cancer genome projects |
Q38110741 | Intravoxel incoherent motion (IVIM) MR imaging of colorectal liver metastases: are we only looking at tumor necrosis? |
Q47396238 | Liver immunotolerance and hepatocellular carcinoma: Patho-physiological mechanisms and therapeutic perspectives. |
Q35531887 | Liver resection for hepatocellular carcinoma in 313 Western patients: tumor biology and underlying liver rather than tumor size drive prognosis. |
Q33508431 | Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation |
Q48341630 | Macrotrabecular-massive hepatocellular carcinoma: A distinctive histological subtype with clinical relevance |
Q83445257 | Non-invasive diagnostic imaging of hepatocellular carcinoma: targeting cellular characterization? |
Q38993647 | Objective response by mRECIST as a predictor and potential surrogate end-point of overall survival in advanced HCC. |
Q36922108 | Oncogenic driver genes and the inflammatory microenvironment dictate liver tumor phenotype |
Q33928170 | Outcomes in adult recipients of right-sided liver grafts in split-liver procedures. |
Q46582065 | PD-020Tolerability and activity of second-line tepotinib, a potent and highly selective c-MET inhibitor, in patients with advanced hepatocellular carcinoma previously treated with sorafenib |
Q37259964 | Performance of bile aspiration plus brushing to diagnose malignant biliary strictures during endoscopic retrograde cholangiopancreatography. |
Q48233798 | Prediction of hepatocellular carcinoma recurrence after liver transplantation: Comparison of four explant-based prognostic models. |
Q40124779 | Progression of fibrosis in patients with chronic viral hepatitis is associated with IL-17(+) neutrophils. |
Q86909217 | Recurrence after liver transplantation for hepatocellular carcinoma according to up-to-seven criteria |
Q40265226 | Recurring multicystic inflammatory pseudotumor of the liver: a case report. |
Q33567122 | Sex Differences in Spontaneous Degranulation Activity of Intrahepatic Natural Killer Cells during Chronic Hepatitis B: Association with Estradiol Levels |
Q48284910 | Sorafenib vs surgical resection for hepatocellular carcinoma with macrovascular invasion: A propensity score analysis. |
Q53326694 | Stabilization of beta-catenin affects mouse embryonic liver growth and hepatoblast fate. |
Q26830194 | Targeting the mTOR pathway in hepatocellular carcinoma: current state and future trends |
Q56384328 | Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study |
Q83739293 | Transplantation for liver failure in patients with sickle cell disease: challenging but feasible |
Q41546596 | Visceral fat area predicts survival in patients with advanced hepatocellular carcinoma treated with tyrosine kinase inhibitors. |
Q60904389 | Voie Wnt/β-caténine et zonation métabolique du foie : un nouvel acteur pour un ancien concept |
Q91337532 | [Application of alpha-fetoprotein and osteopontin combination for early diagnosis of hepatocellular carcinoma associated with hepatitis C.] |
Q53209403 | [Evaluation of noninvasive diagnostic criteria for hepatocellular carcinoma on pretransplant MRI (2010): correlation between MR imaging features and histological features on liver specimen]. |
Q84393654 | [Liver transplantation for hepatocellular carcinoma and for patients with pre-existing cancers] |
Q30512422 | Sabine Colnot | doctoral student | P185 |
Search more.